Data / Research funding / Autoimmune Disease
Autoimmune Disease: 3,837 NIH awards ($4.8B) to 494 organizations
3,837 NIH awards ($4.8B) in the NIH spending category Autoimmune Disease, to 494 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 3,837 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Immune Tolerance Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $203,912,588 | February 1, 2014 | January 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Data Coordinating Center for Type 1 Diabetes TrialNet | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $99,686,705 | September 30, 2015 | May 31, 2030 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $73,059,202 | April 28, 2021 | December 31, 2026 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Regulation of B cell Responses in SLE and Other Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $53,786,694 | May 1, 2014 | April 30, 2029 | SANZ, IGNACIO E. | reporter.nih.gov |
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $37,867,556 | September 20, 2016 | June 30, 2029 | NAJI, ALI | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $32,128,916 | February 1, 2025 | January 31, 2026 | MILLIN, CHRISTINA | reporter.nih.gov |
| RhoFED CDSMC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,374,518 | May 8, 2023 | April 30, 2028 | SCHMIDT, PETER N. | reporter.nih.gov |
| Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $19,999,721 | April 13, 2020 | March 31, 2024 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $19,601,747 | March 23, 2022 | December 31, 2026 | GUTHRIDGE, JOEL MARVIN | reporter.nih.gov |
| Center for Quantitative Biology: A focus on "omics", from organisms to single cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $17,122,562 | August 1, 2019 | June 30, 2029 | WHITFIELD, MICHAEL L | reporter.nih.gov |
| Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $17,043,926 | September 17, 2020 | July 31, 2025 | CHINCHILLI, VERNON M | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,990,990 | August 1, 2008 | June 30, 2030 | DIAMOND, BETTY | reporter.nih.gov |
| Integrated Islet Distribution Program (U24) - 2021 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $14,918,013 | September 30, 2012 | July 31, 2027 | NILAND, JOYCE CAROL | reporter.nih.gov |
| Advancing cross-disease comparisons through FAIR data practices to uncover shared molecular mechanisms between Alzheimer's disease and autoimmune disorders | NIH | National Institute on Aging | 2021 to 2025 | $14,514,376 | September 1, 2025 | April 30, 2027 | HEATH, LAURA MICHELLE | reporter.nih.gov |
| University of Michigan Data Coordinating Center for the Diabetic Foot Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,554,809 | July 1, 2019 | December 31, 2027 | SPINO, CATHERINE A | reporter.nih.gov |
| Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $13,003,302 | July 8, 2022 | June 30, 2027 | MAAHS, DAVID MATTHEW | reporter.nih.gov |
| Functional Microbiomics, Inflammation and Pathogenicity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,492,994 | March 1, 2018 | February 29, 2028 | LAMONT, RICHARD J | reporter.nih.gov |
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $8,401,766 | April 1, 2023 | March 31, 2028 | HYAMS, JEFFREY SAMUEL | reporter.nih.gov |
| Central Hub for Kidney Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $8,320,420 | July 1, 2024 | June 30, 2027 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| Immunotherapy for Ocular Surface Diseases | NIH | National Eye Institute | 2021 to 2025 | $8,312,140 | February 1, 2021 | December 31, 2026 | JAIN, SANDEEP | reporter.nih.gov |
| KPMP Kidney Mapping and Atlas Project (KMAP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,070,448 | September 20, 2022 | June 30, 2027 | KRETZLER, MATTHIAS | reporter.nih.gov |
| Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,890,535 | September 30, 2002 | June 30, 2027 | CHO, JUDY H. | reporter.nih.gov |
| Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,703,361 | September 15, 2014 | June 30, 2029 | KADDIS, JOHN S. | reporter.nih.gov |
| Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,571,345 | December 1, 1996 | December 31, 2027 | KAHN, STEVEN EMANUEL | reporter.nih.gov |
| The Biostatistics Research Center for the Impaired Awareness of Hypoglycemia Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,517,806 | September 25, 2022 | December 31, 2027 | CHINCHILLI, VERNON M | reporter.nih.gov |
| Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $7,269,328 | March 15, 2023 | February 29, 2028 | DULAI, PARAMBIR SINGH | reporter.nih.gov |
| Identifying Immune and Epithelial Network Signatures in Very Early Onset Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $7,187,152 | September 15, 2020 | June 30, 2026 | SNAPPER, SCOTT B | reporter.nih.gov |
| Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,099,019 | August 1, 2022 | May 31, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| SYSTEM ADMINISTRATION AND MANAGEMENT SUPPORT FOR BIOMEDICAL AND BIBLIOGRAPHIC INFORMATION RESOURCES | NIH | National Cancer Institute | 2023 to 2025 | $6,614,179 | September 28, 2023 | September 27, 2026 | FREELAND, KATHRYN | reporter.nih.gov |
| The Cleveland Digestive Diseases Research Core Center (DDRCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,425,666 | February 15, 2015 | August 31, 2030 | COMINELLI, FABIO | reporter.nih.gov |
| Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $6,366,452 | September 20, 2022 | August 31, 2027 | LAFYATIS, ROBERT A. | reporter.nih.gov |
| Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,798 | August 20, 2021 | May 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $6,265,868 | February 1, 2021 | November 30, 2026 | POTTER, HUNTINGTON | reporter.nih.gov |
| Interferon Signaling in the T1D Islet Microenvironment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,240,105 | September 15, 2020 | August 31, 2029 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,122,586 | September 1, 2019 | May 31, 2025 | CHANG, EUGENE B | reporter.nih.gov |
| Integration of immune cell subtypes across diseases & tissue | NIH | National Institute on Aging | 2021 to 2022 | $5,948,190 | September 30, 2018 | August 31, 2023 | DE JAGER, PHILIP L | reporter.nih.gov |
| Metabolic gatekeepers in B-cell malignancies | NIH | National Cancer Institute | 2021 to 2025 | $5,936,594 | April 1, 2016 | August 31, 2028 | MÜSCHEN, MARKUS | reporter.nih.gov |
| Spatial and temporal resolution to dissect cellular circuits controlling intestinal physiology, immunity, and inflammatory pathologies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $5,934,972 | August 1, 2023 | May 31, 2028 | XAVIER, RAMNIK J | reporter.nih.gov |
| Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,810,225 | September 19, 2013 | June 30, 2025 | SARTOR, RYAN B | reporter.nih.gov |
| Sjögren’s Team for Accelerating Medicines Partnership (STAMP) | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $5,801,518 | March 7, 2022 | December 31, 2026 | SHIBOSKI, CAROLINE HELENE | reporter.nih.gov |
| The Role of B cells in the Origin and Progression of Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,776,308 | May 1, 2019 | April 30, 2027 | HAUSER, STEPHEN L | reporter.nih.gov |
| Environmental Biosensors in the Oligodendrocyte Lineage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,732,603 | May 15, 2019 | April 30, 2027 | CASACCIA, PATRIZIA | reporter.nih.gov |
| SLE Treatment with N-acetylcysteine | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $5,581,470 | June 15, 2020 | May 31, 2027 | PERL, ANDRAS | reporter.nih.gov |
| The Columbia PCC for CureGN: the Cure Glomerulonephropathy network | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,398,076 | September 16, 2013 | May 31, 2029 | BOMBACK, ANDREW STEPHEN | reporter.nih.gov |
| Determinants of inception of inflammation in inflammatory bowel diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,397,834 | August 24, 2021 | May 31, 2027 | ANANTHAKRISHNAN, ASHWIN N | reporter.nih.gov |
| Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,241,422 | July 21, 2020 | June 30, 2027 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,235,383 | September 18, 2019 | June 30, 2025 | WANG, DAVID | reporter.nih.gov |
| Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,233,917 | July 1, 2020 | June 30, 2026 | ONTANEDA, DANIEL | reporter.nih.gov |
| CureGN-Penn PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,209,008 | September 16, 2013 | May 31, 2029 | HOLZMAN, LAWRENCE B. | reporter.nih.gov |
| Understanding Neurocognition in Youth with Type 1 Diabetes (UNYT1D) Biostatistics Research Center (BRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $5,150,596 | August 15, 2024 | June 30, 2029 | HELGESON, ERIKA S. | reporter.nih.gov |
| Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $5,148,251 | March 21, 2022 | December 31, 2026 | BUYON, JILL P | reporter.nih.gov |
| Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,112,288 | May 1, 2019 | April 30, 2029 | PASCUAL, MARIA VIRGINIA | reporter.nih.gov |
| Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,061,587 | May 10, 2021 | April 30, 2027 | TRAPNELL, BRUCE C | reporter.nih.gov |
| Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $5,036,160 | September 1, 2022 | August 31, 2027 | CHANG, AILEEN | reporter.nih.gov |
| Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,035,116 | May 21, 2020 | April 30, 2026 | SACHS, DAVID H | reporter.nih.gov |
| Utility of Random Biopsies in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $5,031,513 | July 1, 2024 | June 30, 2029 | LEWIS, JAMES D | reporter.nih.gov |
| Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,027,415 | January 1, 2020 | December 31, 2025 | CALABRESI, PETER A | reporter.nih.gov |
| Determinants of follicular helper T cell expansion in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,994,422 | July 8, 2020 | July 31, 2029 | MOREL, LAURENCE | reporter.nih.gov |
| Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,856,116 | September 15, 2021 | August 31, 2026 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,842,777 | April 1, 2022 | March 31, 2027 | KOTH, LAURA L | reporter.nih.gov |
| Delineating mechanisms of skeletal fragility in older adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,798,865 | February 1, 2021 | January 31, 2027 | YU, ELAINE WEI-YIN | reporter.nih.gov |
| The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $4,768,587 | July 15, 2022 | April 30, 2027 | BRUNNER, HERMINE I | reporter.nih.gov |
| Activation of Macrophages in Human Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,710,162 | March 1, 2000 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,709,163 | May 15, 2014 | August 31, 2023 | ZHANG, BIN | reporter.nih.gov |
| Chemical probes to decipher PAD biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,690,000 | June 1, 2016 | May 31, 2026 | THOMPSON, PAUL R | reporter.nih.gov |
| PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,670,835 | August 5, 2022 | May 31, 2027 | CHEN, YONG | reporter.nih.gov |
| Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $4,541,273 | September 17, 2019 | August 31, 2026 | TING, JENNY P | reporter.nih.gov |
| CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,521,564 | September 16, 2013 | May 31, 2029 | SMOYER, WILLIAM E | reporter.nih.gov |
| AIM-for-RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $4,499,382 | March 22, 2022 | December 31, 2026 | ANOLIK, JENNIFER HOWITT | reporter.nih.gov |
| Unraveling microprotein biology with an evolutionary-immunological framework | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $4,468,145 | September 8, 2023 | August 31, 2028 | CARVUNIS, ANNE-RUXANDRA | reporter.nih.gov |
| Unified and fair multimodal representation learning for autoimmune diseases | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,435,452 | September 16, 2024 | September 15, 2026 | SHEIKH, SAIRA Z | reporter.nih.gov |
| JAK Inhibition in Down Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $4,419,892 | September 25, 2019 | July 31, 2025 | ESPINOSA, JOAQUIN M. | reporter.nih.gov |
| Neonatal porcine islet xenografts for the treatment of type 1 diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,363,576 | September 1, 2010 | June 30, 2025 | KIRK, ALLAN D. | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| CureGN-3: UNCPCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,280,738 | September 16, 2013 | May 31, 2029 | FALK, RONALD J | reporter.nih.gov |
| Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,276,659 | September 17, 2021 | May 31, 2027 | LIU, JIA | reporter.nih.gov |
| Neurovascular Interactions: Mechanisms, imaging, therapeutic potential | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,247,898 | September 1, 2016 | August 31, 2025 | AKASSOGLOU, KATERINA | reporter.nih.gov |
| Predictive drivers of new onset, relapse, and progression of human autoimmunity in skin | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,237,221 | April 20, 2023 | March 31, 2026 | HARRIS, JOHN E | reporter.nih.gov |
| Cytokine regulation of mucosal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,234,402 | June 6, 2019 | June 30, 2029 | SONNENBERG, GREGORY F | reporter.nih.gov |
| : Clinical Outcomes in Aicardi Goutières Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,216,994 | July 1, 2019 | June 30, 2025 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,185,542 | September 15, 2023 | June 30, 2028 | LEBWOHL, BENJAMIN | reporter.nih.gov |
| Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,125,381 | May 1, 2021 | April 30, 2027 | GAFFNEY, PATRICK M | reporter.nih.gov |
| Multi-racial genetic analysis of hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $4,095,633 | July 16, 2021 | June 30, 2026 | LIAO, WILSON | reporter.nih.gov |
| Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,067,768 | May 1, 2021 | April 30, 2027 | BALKO, JUSTIN M | reporter.nih.gov |
| Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,017,799 | March 22, 2023 | February 29, 2028 | KARP, DAVID R | reporter.nih.gov |
| Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,971,090 | September 30, 2021 | June 30, 2026 | DEVKOTA, SUZANNE | reporter.nih.gov |
| Type 1 Diabetes TrialNet Clinical Network Hub | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,959,999 | September 9, 2014 | May 31, 2030 | GREENBAUM, CARLA J | reporter.nih.gov |
| High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,939,372 | April 15, 2021 | March 31, 2027 | LI, HONGMIN | reporter.nih.gov |
| Molecular basis of bioelectronic medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,937,630 | May 1, 2016 | April 30, 2027 | TRACEY, KEVIN J | reporter.nih.gov |
| Harnessing engineered T regulatory cells to promote beta cell health in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,920,533 | April 8, 2022 | January 31, 2026 | BUCKNER, JANE HOYT | reporter.nih.gov |
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| Autoimmune Drivers and Protectors Team Science (ADAPTS) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,860,822 | March 1, 2023 | February 29, 2028 | JAMES, JUDITH A | reporter.nih.gov |
| RESOURCE BASED CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,860,791 | April 15, 2019 | June 30, 2029 | SILVA, MATTHEW J | reporter.nih.gov |
| Mechanisms and pathophysiologic impact of claudin-2 modulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,845,865 | September 29, 2001 | June 30, 2028 | TURNER, JERROLD R. | reporter.nih.gov |
| Integrative analysis of multi-omic signatures and cellular function in human pancreas across developmental timeline at single-cell spatial resolution | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,809,484 | September 20, 2022 | June 30, 2027 | BRISSOVA, MARCELA | reporter.nih.gov |
| Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,767,518 | February 23, 2021 | January 31, 2027 | WELLS, ANDREW D | reporter.nih.gov |
| Modulating Glial Fate and Function in Development and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,751,910 | May 1, 2020 | April 30, 2028 | TESAR, PAUL JOSEPH | reporter.nih.gov |
| Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial | NIH | National Eye Institute | 2021 to 2023 | $3,733,343 | May 1, 2019 | April 30, 2026 | ACHARYA, NISHA | reporter.nih.gov |
| Studies on the structure of basement membranes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,732,265 | September 1, 1986 | June 30, 2029 | HUDSON, BILLY GERALD | reporter.nih.gov |
| Differentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain Imaging | NIH | National Eye Institute | 2022 to 2025 | $3,722,281 | September 30, 2022 | August 31, 2027 | MOULTON, ERIC ALAN | reporter.nih.gov |
| An interactive resource to generate and provide integrated knowledge of the human pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,713,324 | February 1, 2024 | November 30, 2028 | GAULTON, KYLE JEFFRIE | reporter.nih.gov |
| CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,704,355 | July 1, 2013 | April 30, 2027 | LEE, YVONNE CLAIRE | reporter.nih.gov |
| Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,700,281 | March 22, 2022 | December 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,692,582 | September 27, 2021 | June 30, 2027 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,664,508 | September 20, 2022 | June 30, 2027 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Reserve against Disability in Early Multiple Sclerosis (RADIEMS) Longitudinal Cohort Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,629,278 | July 11, 2016 | July 31, 2026 | SUMOWSKI, JAMES FRANCIS | reporter.nih.gov |
| ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial | NIH | National Eye Institute | 2021 to 2022 | $3,613,158 | September 30, 2018 | August 31, 2025 | HOLBROOK, JANET T. | reporter.nih.gov |
| Mechanisms associated with flares and remission in colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,593,722 | May 1, 2017 | May 31, 2026 | LIRA, SERGIO A. | reporter.nih.gov |
| Regulators of immune complex mediated neutrophil antigen presentation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,580,976 | September 30, 1999 | February 28, 2027 | MAYADAS, TANYA N | reporter.nih.gov |
| Epigenetics of the autoantibody response in systemic lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,576,652 | September 24, 2021 | August 31, 2026 | CASALI, PAOLO | reporter.nih.gov |
| Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $3,549,010 | July 8, 2021 | February 28, 2027 | SHARMA, SONIA | reporter.nih.gov |
| Translating Scientific Evidence into Practice using Digital Medicine and Electronic Patient Reported Outcomes | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $3,537,149 | April 20, 2020 | March 31, 2025 | SANDS, BRUCE E | reporter.nih.gov |
| Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,518,173 | February 1, 2023 | January 31, 2028 | BEATON, ANDREA ZAWACKI | reporter.nih.gov |
| Insights Into Immune-Related Diseases Born from Population Genomics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,513,383 | July 6, 2010 | July 31, 2030 | NORMAN, PAUL JOHN | reporter.nih.gov |
| Design and development of HDAC11-specific chemical inhibitors for disease treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,482,034 | March 1, 2021 | February 28, 2027 | SETO, EDWARD | reporter.nih.gov |
| Disparities in cardiovascular health in young adults with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,472,802 | September 1, 2024 | May 31, 2028 | DABELEA, DANA | reporter.nih.gov |
| Defining mechanisms of disease and repair in a viral model of multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,467,101 | May 1, 2020 | April 30, 2029 | LANE, THOMAS E | reporter.nih.gov |
| Role of Transglutaminase 2 in Celiac Sprue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,463,787 | September 20, 2003 | April 30, 2026 | KHOSLA, CHAITAN | reporter.nih.gov |
| Pathogenesis of Neurological Disability in Primary Diseases of Myelin | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,460,848 | December 1, 2016 | November 30, 2025 | TRAPP, BRUCE D | reporter.nih.gov |
| Epigenetic Checkpoint Regulation of Naive T-cell Quiescence and Peripheral Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,428,212 | July 22, 2025 | June 30, 2029 | FENG, YONGQIANG | reporter.nih.gov |
| Characterization of Mucosal Lymphocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,410,819 | September 30, 1992 | June 30, 2029 | BLUMBERG, RICHARD S | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| CAR-T cell treatment of CNS Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,403,175 | June 13, 2022 | May 31, 2027 | WU, GREGORY | reporter.nih.gov |
| Cholesterol reduction and cardiovascular risk in Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,394,086 | August 5, 2022 | July 31, 2027 | GOLDBERG, IRA J | reporter.nih.gov |
| Microphysiological systems for modeling autoimmunity in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,372,768 | August 2, 2019 | July 31, 2025 | STANGER, BEN Z | reporter.nih.gov |
| Functional and Mechanistic Characterization of Lupus Susceptibility | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,364,935 | September 3, 2025 | August 31, 2029 | NATH, SWAPAN K. | reporter.nih.gov |
| Integration of genomics and transcriptomics to investigate biological pathways in very early onset IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,353,628 | July 1, 2021 | April 30, 2027 | KELSEN, JUDITH RACHEL | reporter.nih.gov |
| Impact of Disparities in Food Security on Glycemic Control and Health CareUtilization Among Youth and Young Adults with Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,349,600 | April 1, 2018 | March 31, 2028 | LIESE, ANGELA D | reporter.nih.gov |
| The PAS Sensor Family and Human Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $3,342,660 | September 15, 2017 | May 31, 2026 | BRADFIELD, CHRISTOPHER A | reporter.nih.gov |
| Periodontitis Role in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,340,009 | September 1, 2025 | August 31, 2029 | THUMBIGERE-MATH, VIVEK | reporter.nih.gov |
| Multiscale genome engineering to map cis-regulatory variants in human and mouse | NIH | National Human Genome Research Institute | 2023 to 2025 | $3,334,063 | September 15, 2023 | June 30, 2027 | SANJANA, NEVILLE | reporter.nih.gov |
| Hydrogels for human beta cell survival, function and evasion of immune rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,331,035 | September 15, 2022 | May 31, 2027 | GARCIA, ANDRES J | reporter.nih.gov |
| Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,328,254 | April 1, 2022 | September 30, 2026 | LIM, WENDELL A | reporter.nih.gov |
| Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,325,791 | April 1, 2022 | March 31, 2027 | KUHNS, MICHAEL S | reporter.nih.gov |
| Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,318,186 | January 5, 2022 | December 31, 2026 | HEINECKE, JAY W | reporter.nih.gov |
| Impact of Registry Use on Quality and Outcomes in Rheumatology (QORA) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,312,228 | July 16, 2021 | May 31, 2027 | SCHMAJUK, GABRIELA | reporter.nih.gov |
| Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,303,112 | September 15, 2020 | June 30, 2025 | SUH, YOUSIN | reporter.nih.gov |
| The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,299,380 | March 4, 2019 | February 28, 2027 | FAITH, JEREMIAH JAMES | reporter.nih.gov |
| Pathogenesis of lung injury mediated by lung-restricted antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,293,690 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,291,872 | July 1, 2020 | June 30, 2025 | ANTHONY, ROBERT MCCULLOUGH | reporter.nih.gov |
| Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy | NIH | National Cancer Institute | 2021 to 2024 | $3,284,686 | September 1, 2019 | August 31, 2025 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Immune modulating therapies to treat complex regional pain syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,283,186 | September 30, 2022 | August 31, 2027 | AJIT, SEENA | reporter.nih.gov |
| Functional outcomes of inflammatory bowel disease associated variants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,272,687 | September 18, 2013 | May 31, 2028 | ABRAHAM, CLARA | reporter.nih.gov |
| Unmodified and Post Translationally Modified CD4+ and CD8+ T cell Epitopes in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,237,408 | September 30, 2019 | September 29, 2023 | BENTON, RYAN | reporter.nih.gov |
| Anti-interneuron antibodies in rapid-onset pediatric OCD: clinical generalization and target identification | NIH | National Institute of Mental Health | 2022 to 2025 | $3,227,070 | September 1, 2022 | June 30, 2027 | PITTENGER, CHRISTOPHER JOHN | reporter.nih.gov |
| Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,216,546 | March 1, 2021 | February 28, 2027 | WEISMAN, GARY ANDREW | reporter.nih.gov |
| Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,205,764 | June 1, 2020 | November 30, 2025 | SHIBOSKI, CAROLINE HELENE | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $3,184,520 | August 15, 2012 | June 30, 2025 | BRAFFETT, BARBARA HALINA | reporter.nih.gov |
| The role of BAF related complexes in regulatory T cell development and function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,171,120 | June 1, 2020 | May 31, 2025 | ZHENG, YE | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,158,683 | July 21, 2016 | June 30, 2027 | CHEN, YI-GUANG | reporter.nih.gov |
| Identification and Characterization of Microbial Metabolites in Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,152,946 | May 26, 2022 | April 30, 2027 | XAVIER, RAMNIK J | reporter.nih.gov |
| Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,147,169 | July 1, 2021 | June 30, 2026 | PARKER, CHRISTOPHER G | reporter.nih.gov |
| Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,140,632 | September 1, 2025 | August 31, 2029 | SNEDDON, JULIE BETH | reporter.nih.gov |
| The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,138,464 | July 5, 2022 | June 30, 2027 | CUDA, CARLA M | reporter.nih.gov |
| Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,134,067 | June 1, 2019 | March 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,130,679 | September 3, 2025 | August 31, 2029 | GORMAN, JACQUELYN | reporter.nih.gov |
| Microbiota-immune interactions that promote intestinal homeostasis | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,111,145 | June 15, 2021 | May 31, 2026 | ROUND, JUNE LOUISE | reporter.nih.gov |
| Engineering T cells to Promote Islet Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,102,316 | April 1, 2022 | March 31, 2027 | RILEY, JAMES L. | reporter.nih.gov |
| Engineered Immune Cells for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,097,818 | April 1, 2022 | March 31, 2026 | MEYER, EVERETT | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,091,101 | June 23, 2021 | April 30, 2026 | ROBINSON, WILLIAM H | reporter.nih.gov |
| An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,085,449 | September 1, 2014 | April 30, 2027 | CHAN, STEPHEN Y | reporter.nih.gov |
| Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,077,928 | July 15, 2021 | June 30, 2027 | CIOFANI, MARIA | reporter.nih.gov |
| Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,074,490 | September 12, 2021 | July 31, 2027 | BRETON, MARC D | reporter.nih.gov |
| NIDDK Diabetic Foot Consortium Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,070,460 | September 15, 2018 | December 31, 2027 | HOLMES, CRYSTAL MURRAY | reporter.nih.gov |
| Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets | NIH | National Institute of Mental Health | 2021 to 2024 | $3,068,428 | April 16, 2020 | January 31, 2026 | WILSON, MICHAEL R | reporter.nih.gov |
| Innate immune regulation of neuroinflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,052,610 | June 1, 2021 | May 31, 2027 | SONNENBERG, GREGORY F | reporter.nih.gov |
| Mechanism of action for the epithelial-specific ER stress sensor IRE1β in regulating intestinal homeostasis and host defense | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,050,147 | September 1, 1993 | March 31, 2026 | LENCER, WAYNE I | reporter.nih.gov |
| PanKbase: a community hub for integrated pancreas knowledge | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,048,518 | February 1, 2024 | November 30, 2028 | PARKER, STEPHEN CJ | reporter.nih.gov |
| Building the foundations of commensal vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,047,222 | September 23, 2022 | August 31, 2027 | FISCHBACH, MICHAEL ANDREW | reporter.nih.gov |
| Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,027,125 | September 1, 2018 | July 31, 2025 | LAZARIDIS, KONSTANTINOS N | reporter.nih.gov |
| Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,023,310 | August 1, 2019 | July 31, 2025 | STABLER, CHERIE L | reporter.nih.gov |
| Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,020,296 | September 15, 2022 | April 30, 2027 | REIJONEN, HELENA KRISTIINA | reporter.nih.gov |
| A 3D vascularized islet biomimetic to model type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,017,660 | August 1, 2019 | January 31, 2025 | SANDER, MAIKE | reporter.nih.gov |
| Identifying cell-type specific genetic control of T1D risk variants in TEDDY | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,014,326 | February 1, 2024 | January 31, 2027 | ONENGUT, SUNA | reporter.nih.gov |
| Cbfb in RORgt-regulated T cell function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,010,210 | May 1, 2014 | May 31, 2029 | SUN, ZUOMING | reporter.nih.gov |
| Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,003,444 | August 25, 2021 | July 31, 2025 | LAFFEL, LORI M | reporter.nih.gov |
| Optimizing detection and prediction of changes in cognitive function in multiple sclerosis with novel ambulatory assessment methods | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,003,354 | August 1, 2021 | July 31, 2027 | KRATZ, ANNA LOUISE | reporter.nih.gov |
| Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,000,544 | September 19, 2022 | July 31, 2027 | DAS, SAUMYA | reporter.nih.gov |
| Development of TP-317 in Ulcerative Colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,996,955 | September 18, 2017 | February 28, 2027 | PARKINSON, JOHN | reporter.nih.gov |
| Salivary gland ionocyte organization and function during homeostasis, repair, and disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,994,334 | August 18, 2021 | May 31, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,992,236 | June 7, 2024 | May 31, 2026 | STEWART, CHARLES ANDREW | reporter.nih.gov |
| Pyrimidine metabolism in the development of autoreactive B cells and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,989,958 | September 1, 2025 | August 31, 2029 | RAHMAN, ZIAUR | reporter.nih.gov |
| The NOTCH Signaling Pathway in Large Vessel Vasculitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,984,128 | January 6, 2014 | June 30, 2027 | WEYAND, CORNELIA M. | reporter.nih.gov |
| Genetically-engineered stem cells for self-regulating arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,983,611 | April 1, 2022 | March 31, 2027 | GUILAK, FARSHID | reporter.nih.gov |
| Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,978,715 | August 18, 2023 | July 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype | NIH | National Institute on Aging | 2021 to 2024 | $2,977,796 | September 30, 2020 | May 31, 2026 | MYASOEDOVA, ELENA | reporter.nih.gov |
| Discriminating the contributions of CCR4 and CCR7 to thymic central tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,972,596 | March 15, 2014 | August 31, 2030 | EHRLICH, LAUREN ILYSE RICHIE | reporter.nih.gov |
| Early detection of type 1 diabetes via Exosome Technology with Optoelectronics Lab-on-chip: EXTOL | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,971,174 | September 15, 2022 | April 30, 2026 | LEE, LUKE P. | reporter.nih.gov |
| Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,957,132 | September 7, 2020 | August 31, 2025 | LESSARD, CHRISTOPHER J | reporter.nih.gov |
| A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,952,468 | May 1, 2020 | June 30, 2025 | FANGER, NEIL A | reporter.nih.gov |
| Identifying and preventing antigen specific T cells in diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,951,339 | June 22, 2021 | May 31, 2027 | FIFE, BRIAN T | reporter.nih.gov |
| Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,942,139 | September 20, 2016 | June 30, 2024 | GHOSH, SOUMITRA | reporter.nih.gov |
| Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,937,551 | April 15, 2022 | March 31, 2027 | WASHKO, GEORGE R | reporter.nih.gov |
| Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,937,157 | May 15, 2022 | April 30, 2027 | WONG, WILSON | reporter.nih.gov |
| A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,936,823 | July 7, 2022 | June 30, 2027 | HAECKER, HANS | reporter.nih.gov |
| Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,936,094 | May 15, 2021 | April 30, 2026 | WILSON, MICHAEL R | reporter.nih.gov |
| UCSF Diabetic Foot Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,932,202 | September 15, 2018 | December 31, 2027 | CONTE, MICHAEL S | reporter.nih.gov |
| Regulation and function of mucosal IgA immune responses to mycobiota in the gut. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,924,410 | June 1, 2021 | May 31, 2027 | ILIEV, ILIYAN DIMITROV | reporter.nih.gov |
| A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,922,693 | February 23, 2021 | January 31, 2025 | FANGER, GARY | reporter.nih.gov |
| Complement in Pathogenesis and Experimental Therapy of ANCA Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,919,656 | July 1, 2020 | June 30, 2025 | SONG, WENCHAO | reporter.nih.gov |
| Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,919,236 | August 1, 2016 | May 31, 2026 | SEFTEL, DAVID | reporter.nih.gov |
| A Novel Probiotic for the Treatment of Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,918,422 | May 12, 2021 | April 30, 2026 | FANGER, GARY | reporter.nih.gov |
| Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,917,818 | July 1, 2005 | June 30, 2029 | TURNER, JERROLD R. | reporter.nih.gov |
| ABIN1 dysfunction in Lupus Nephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,909,013 | September 1, 2021 | June 30, 2027 | POWELL, DAVID W. | reporter.nih.gov |
| iSTAR Tregs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,906,574 | July 1, 2023 | June 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,902,111 | April 15, 2021 | March 31, 2026 | LUCAS, CARRIE L. | reporter.nih.gov |
| Improving Self-Regulation and Social Support for Type 1 Diabetes During Emerging Adulthood | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,899,970 | May 1, 2022 | April 30, 2027 | BERG, CYNTHIA A | reporter.nih.gov |
| Depleting autoantibodies for the treatment of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,898,618 | March 11, 2022 | February 28, 2027 | KANNANGANAT SIDHARTHAN, SUNIL | reporter.nih.gov |
| Role of CREM in Amebic Colitis and Inflammatory Bowel Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,896,698 | August 1, 1989 | December 31, 2027 | PETRI, WILLIAM A | reporter.nih.gov |
| Dietary fat-activated colonocyte-macrophage ketone shuttle drives intestinal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,893,480 | July 18, 2025 | June 30, 2029 | RUAN, HAI-BIN | reporter.nih.gov |
| Enhancement of autoimmunity in type 1 diabetes by gluten | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,890,025 | September 17, 2021 | August 31, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| The role of cytotoxic T cells in rheumatoid arthritis pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,877,343 | September 1, 2021 | August 31, 2026 | ANDRADE, FELIPE | reporter.nih.gov |
| The Biogenesis of Platelet-Derived Extracellular Vesicles and their Impact on Megakaryocyte Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,874,833 | April 20, 2021 | March 31, 2027 | MACHLUS, KELLIE RAE | reporter.nih.gov |
| Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $2,866,312 | August 17, 2023 | July 31, 2028 | IZMIRLY, PETER | reporter.nih.gov |
| Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,865,164 | September 17, 2020 | June 30, 2024 | BRETON, MARC D | reporter.nih.gov |
| Characterize the Landscape and Origin of Hybrid Peptides in Beta Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,864,714 | September 25, 2018 | June 30, 2027 | DELONG, THOMAS | reporter.nih.gov |
| Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,862,122 | July 21, 2023 | June 30, 2027 | QIAN, WEI-JUN | reporter.nih.gov |
| Vasculopathy and Systemic Sclerosis-Associated Interstitial Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,859,896 | August 10, 2022 | July 31, 2027 | BERNSTEIN, ELANA J. | reporter.nih.gov |
| TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,853,080 | July 10, 2020 | June 30, 2026 | LUND, FRANCES E. | reporter.nih.gov |
| Genetic regulation of epithlial injury in ulcerative colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,842,245 | September 22, 2025 | September 21, 2029 | KATTAH, MICHAEL GEORGE | reporter.nih.gov |
| The role of senescent beta cells in T1D and T2D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,840,914 | September 19, 2022 | June 30, 2027 | KAESTNER, KLAUS H | reporter.nih.gov |
| Development of platforms for beta cell-specific delivery and ligand discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,837,648 | July 1, 2023 | June 30, 2027 | CHOUDHARY, AMIT | reporter.nih.gov |
| Intestinal Inflammation: Signaling proteins and the rate of PMN transmigration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,831,952 | October 1, 2002 | April 30, 2027 | PARKOS, CHARLES A | reporter.nih.gov |
| Role of mitochondria in SLE and its cardiovascular complications | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,831,874 | August 25, 2021 | June 30, 2026 | LOOD, JAN CHRISTIAN | reporter.nih.gov |
| Absorption of vitamin B1 along the intestinal tract: Physiology, pathophysiology and cell biology aspects | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,831,663 | August 1, 1999 | December 31, 2025 | SAID, HAMID M | reporter.nih.gov |
| Molecular Determinants of Usual Interstitial Pneumonia (UIP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,826,957 | April 1, 2022 | March 31, 2027 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Polyamines and Hypusine in Type 1 Diabetes Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,825,507 | May 7, 2020 | July 31, 2030 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics with Multiple Sclerosis | NIH | National Institute on Minority Health and Health Disparities | 2025 | $2,825,047 | September 14, 2025 | June 30, 2029 | GEE, STEPHANIE SILVEIRA | reporter.nih.gov |
| Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,822,766 | February 1, 2021 | December 31, 2025 | JACKSON, SHAUN WILLIAM | reporter.nih.gov |
| Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,817,305 | July 1, 2022 | April 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Multimarker surface signatures of human islet derived extracellular vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,815,725 | September 22, 2022 | May 31, 2027 | ROUTENBERG, DAVID AARON | reporter.nih.gov |
| Latent TGF-β2 Structure and Activation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,811,726 | April 1, 2022 | March 31, 2026 | SPRINGER, TIMOTHY A | reporter.nih.gov |
| Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,809,344 | August 1, 2021 | July 31, 2026 | LITTMAN, DAN | reporter.nih.gov |
| BCAP regulation of TLR7/9 signaling in Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,809,161 | December 1, 2019 | November 30, 2025 | HAMERMAN, JESSICA A | reporter.nih.gov |
| Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,807,438 | June 15, 2022 | May 31, 2027 | SOLOMON, DANIEL HAL | reporter.nih.gov |
| Toward a Validated in Vivo Imaging Marker of Axonal Damage Predictive of Progressive Disability in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,805,313 | April 1, 2021 | March 31, 2027 | HUANG, SUSIE YI | reporter.nih.gov |
| Precise Infliximab Exposure and Pharmacodynamic Control to Achieve Deep Remission in Pediatric Crohn's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,803,917 | June 1, 2022 | March 31, 2027 | MINAR, PHILLIP P | reporter.nih.gov |
| WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,801,318 | February 10, 2021 | January 31, 2026 | IRITANI, BRIAN M | reporter.nih.gov |
| Bacterial metabolites controlling Th17 and Treg cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,799,466 | September 1, 2016 | July 31, 2025 | HUH, JUN R. | reporter.nih.gov |
| Monitoring Disease in Lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,798,512 | March 8, 2019 | June 30, 2029 | MOHAN, CHANDRA | reporter.nih.gov |
| Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,795,439 | June 1, 2022 | March 31, 2027 | CHAIKOF, ELLIOT | reporter.nih.gov |
| Comprehensive Proteomic Classifier for the Molecular Characterization of Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,790,619 | August 15, 2021 | July 31, 2025 | BHARGAVA, MANEESH | reporter.nih.gov |
| Whole Protein Arrays to Detect Antimicrobial Antibodies Associated with Triggering and Progression of Islet Autoimmunity in TEDDY | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,788,474 | September 5, 2024 | August 31, 2027 | LABAER, JOSHUA | reporter.nih.gov |
| Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,784,187 | August 2, 2013 | March 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| Survival and potential of insulin-deficient beta cells in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,780,326 | September 20, 2022 | June 30, 2027 | SCHATZ, DESMOND ARTHUR | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Restoring Immune Balance in Hiddradenitis Suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,776,428 | May 1, 2020 | April 30, 2026 | ROSENBLUM, MICHAEL DAVID | reporter.nih.gov |
| Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,773,326 | September 28, 2009 | March 31, 2026 | KOVATCHEV, BORIS P | reporter.nih.gov |
| Treating colon cancer by regulating intestinal immunity through microbial metabolism | NIH | National Cancer Institute | 2021 to 2025 | $2,772,249 | June 1, 2021 | May 31, 2027 | ARPAIA, NICHOLAS | reporter.nih.gov |
| Supramolecular biomaterials for tuning the inflammatory properties of the complement system | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,759,425 | June 1, 2022 | May 31, 2027 | COLLIER, JOEL H | reporter.nih.gov |
| Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,758,753 | September 19, 2022 | June 30, 2027 | NG, ALPHONSUS | reporter.nih.gov |
| Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,751,010 | September 23, 2021 | August 31, 2026 | SUNDRUD, MARK SCOTT | reporter.nih.gov |
| Harnessing the anti-inflammatory activity of extracellular sialylation of IgG. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,749,084 | April 16, 2021 | March 31, 2026 | ANTHONY, ROBERT MCCULLOUGH | reporter.nih.gov |
| Dupilumab in the Treatment of Pediatric Alopecia Areata | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,738,616 | May 15, 2024 | April 30, 2029 | GUTTMAN, EMMA | reporter.nih.gov |
| Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,738,039 | September 1, 2021 | May 31, 2028 | TANGNEY, JARED RYLAN | reporter.nih.gov |
| Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,734,575 | December 1, 2021 | November 30, 2026 | BIDDINGER, SUDHA B | reporter.nih.gov |
| Nlrp3 inflammasome activation in early diabetic retinopathy | NIH | National Eye Institute | 2021 to 2024 | $2,726,569 | September 1, 2020 | May 31, 2025 | AMBATI, JAYAKRISHNA | reporter.nih.gov |
| Mechanisms of cannabidiol in persons with MS: the role of sleep and pain phenotype | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,725,289 | August 15, 2021 | May 31, 2026 | BRALEY, TIFFANY JOY | reporter.nih.gov |
| Identification and characterization of inflammatory bowel disease causal variants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,724,317 | August 15, 2022 | June 30, 2027 | HUANG, HAILIANG | reporter.nih.gov |
| Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,718,736 | July 1, 2022 | June 30, 2027 | LIAO, KATHERINE PHOENIX | reporter.nih.gov |
| Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,718,093 | September 19, 2022 | July 31, 2027 | SIMS, EMILY K | reporter.nih.gov |
| [18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events | NIH | National Cancer Institute | 2022 to 2025 | $2,714,023 | September 1, 2022 | August 31, 2027 | PIWNICA-WORMS, DAVID | reporter.nih.gov |
| Development of a B Cell Therapeutic | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,713,112 | August 20, 2020 | July 31, 2025 | DITTEL, BONNIE N | reporter.nih.gov |
| Establishing Readiness of Dental Professionals in Practice-Based Research and Inter-Professional Care | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,709,841 | September 13, 2023 | June 30, 2028 | THYVALIKAKATH, THANKAM P | reporter.nih.gov |
| Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,708,611 | September 7, 2020 | June 30, 2026 | MOWRY, ELLEN M. | reporter.nih.gov |
| Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,708,550 | July 15, 2021 | June 30, 2025 | HEROLD, KEVAN C | reporter.nih.gov |
| ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,707,952 | August 17, 2022 | May 31, 2027 | KOVATCHEV, BORIS P | reporter.nih.gov |
| Dietary Regulation of Intestinal Inflammation and Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,700,479 | March 15, 2022 | January 31, 2027 | ARTIS, DAVID | reporter.nih.gov |
| Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,697,814 | May 15, 2023 | April 30, 2031 | VOSKUHL, RHONDA R | reporter.nih.gov |
| Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,694,152 | September 16, 2013 | July 31, 2025 | THANNICKAL, VICTOR J. | reporter.nih.gov |
| Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,693,358 | July 1, 2020 | May 31, 2025 | FALK, RONALD J | reporter.nih.gov |
| Immunology of advancing disease among minorities with Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,692,372 | July 1, 2021 | May 31, 2027 | MONSON, NANCY L | reporter.nih.gov |
| Regulation of neutrophil plasticity, heterogenicity, and functional ambivalency by WNT5 in colitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,685,326 | July 7, 2025 | June 30, 2029 | WU, DIANQING | reporter.nih.gov |
| A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,684,733 | August 1, 2024 | May 31, 2027 | GILKESON, GARY S | reporter.nih.gov |
| B-lymphocyte Targeting Therapies for Autoimmune Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,678,494 | April 1, 2013 | March 31, 2026 | SERREZE, DAVID V | reporter.nih.gov |
| Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,674,708 | March 31, 2021 | February 28, 2026 | WILSON, KEITH T. | reporter.nih.gov |
| Mechanisms of sphingolipid signaling in vascular health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,673,681 | January 18, 2017 | December 31, 2023 | HLA, TIMOTHY TUN | reporter.nih.gov |
| Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,665,061 | May 1, 2009 | April 30, 2026 | GHARAVI, ALI G | reporter.nih.gov |
| Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,560 | March 1, 2022 | February 28, 2027 | SHUM, ANTHONY | reporter.nih.gov |
| Macrophage Heterogeneity in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,660,867 | April 15, 2022 | February 28, 2027 | WINTER, DEBORAH RACHELLE | reporter.nih.gov |
| SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,658,806 | June 1, 1998 | June 30, 2027 | DEFRONZO, RALPH A | reporter.nih.gov |
| Autoimmune Stem-like CD8 T cells in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,657,421 | June 8, 2023 | May 31, 2028 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Administrative Supplement to Investigate the Effects of Long COVID on SELA study participants | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,657,323 | July 28, 2021 | April 30, 2026 | RAMOS, PAULA SOFIA | reporter.nih.gov |
| The Role of Crypt Fissioning in IBD Ulcer Healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,649,727 | February 24, 2021 | January 31, 2026 | BARRETT, TERRENCE A. | reporter.nih.gov |
| Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,640,352 | September 1, 2022 | August 31, 2027 | PARDO-VILLAMIZAR, CARLOS A | reporter.nih.gov |
| Type 1 diabetes genetic risk scores for the diagnosis of diabetes type in children of diverse racial and ethnic background | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,640,074 | February 15, 2021 | January 31, 2026 | REDONDO, MARIA JOSE | reporter.nih.gov |
| Lymphatic regulation of lymph node function in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,639,789 | February 1, 2010 | January 31, 2028 | LU, THERESA T. | reporter.nih.gov |
| Gut bacterial metallophores in the development and severity of inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,638,713 | April 1, 2022 | February 28, 2027 | SAMUELSON, DERRICK R | reporter.nih.gov |
| Natural History of Pre-Diabetic Autoimmunity (DAISY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,635,445 | November 1, 1994 | April 30, 2026 | REWERS, MARIAN J | reporter.nih.gov |
| Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,634,144 | August 12, 2022 | July 31, 2026 | ANDERSON, MARK S | reporter.nih.gov |
| Role of GRAIL in B cell tolerance and B-cell mediated inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,630,572 | August 1, 2025 | July 31, 2029 | NURIEVA, ROZA INSAFETDINOVNA | reporter.nih.gov |
| Modulating pathogenic T cells in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,630,520 | April 1, 2000 | May 31, 2029 | HEROLD, KEVAN C | reporter.nih.gov |
| Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,622,833 | July 31, 2022 | May 31, 2027 | ALLEN, JACOB MATTHEW | reporter.nih.gov |
| Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,620,275 | September 23, 2020 | August 31, 2025 | ARDITI, MOSHE | reporter.nih.gov |
| Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,617,623 | June 1, 2022 | March 31, 2027 | SAHIN, ERGUN | reporter.nih.gov |
| Role of the environmental sensor, AhR on colitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,615,887 | September 27, 2021 | August 31, 2027 | NAGARKATTI, PRAKASH S | reporter.nih.gov |
| ACT1VATE: Addressing Emotional Distress to Improve Outcomes among Diverse Adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,615,237 | September 15, 2020 | August 31, 2027 | FORTMANN, ADELAIDE L | reporter.nih.gov |
| The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,613,461 | March 11, 2021 | January 31, 2027 | MOTTL, AMY | reporter.nih.gov |
| Development of Immune Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,613,354 | March 15, 2016 | February 28, 2027 | FARRAR, MICHAEL ARCHIBALD | reporter.nih.gov |
| Pandemrix and T Cell Immunology in Narcolepsy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,607,677 | May 13, 2021 | April 30, 2025 | MIGNOT, EMMANUEL J | reporter.nih.gov |
| Pathogenesis of Primary Biliary Cholangitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,607,525 | December 21, 2020 | November 30, 2025 | LAZARIDIS, KONSTANTINOS N | reporter.nih.gov |
| Autoantibodies define scleroderma subgroups with distinct relationships to cancer | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,606,356 | April 9, 2018 | July 31, 2029 | SHAH, AMI AALOK | reporter.nih.gov |
| Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,600,290 | July 15, 2024 | June 30, 2027 | SCARNEO, SCOTT | reporter.nih.gov |
| Neutrophil plasticity in autoimmune disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,593,636 | February 10, 2020 | January 31, 2026 | MAYADAS, TANYA N | reporter.nih.gov |
| Determining genomic and host-environment contributions to IBD phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,592,024 | September 30, 2022 | June 30, 2027 | MCGOVERN, DERMOT PATRICK | reporter.nih.gov |
| Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,589,752 | March 15, 2021 | July 6, 2026 | LITTMAN, DAN | reporter.nih.gov |
| Intestinal surveillance by intraepithelial lymphocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,589,419 | July 1, 2017 | April 30, 2026 | MUCIDA, DANIEL S | reporter.nih.gov |
| Generating spatial and functional maps of cell-to-cell interactions in MS lesions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,587,248 | March 15, 2021 | February 28, 2026 | PITT, DAVID | reporter.nih.gov |
| Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,578,394 | February 7, 2020 | January 31, 2026 | MAAHS, DAVID MATTHEW | reporter.nih.gov |
| Micro-TeACH (Microbiome Technology and Analytic Center Hub) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,568,320 | March 10, 2022 | December 31, 2026 | SCHER, JOSE U. | reporter.nih.gov |
| Dietary fiber and soy protein-based microbiome metabolites for IBD prevention | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,557,667 | July 3, 2018 | December 31, 2026 | MARTENS, ERIC C | reporter.nih.gov |
| Regulatory and Mechanistic Understanding of ADAR-Mediated RNA Editing | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,555,687 | June 1, 2022 | April 30, 2027 | LI, JIN BILLY | reporter.nih.gov |
| Engineering IgG-specific endoglycosidases to selectively defeat effector functions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,552,024 | April 8, 2020 | April 30, 2030 | SUNDBERG, ERIC JOHN | reporter.nih.gov |
| Three-dimensional conformation changes associated with T cell memory and autoimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,550,277 | September 15, 2020 | June 30, 2025 | HAWKINS, RAYMOND DAVID | reporter.nih.gov |
| Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,545,042 | July 21, 2023 | June 30, 2027 | HOOFNAGLE, ANDREW N | reporter.nih.gov |
| Functional consequences of intergenic autoimmune disease risk variants | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,539,964 | March 3, 2023 | February 29, 2028 | NIEWOLD, TIMOTHY B | reporter.nih.gov |
| Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,539,894 | September 17, 2021 | June 30, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,536,849 | June 1, 2021 | March 31, 2026 | SARMA, ARUNA V | reporter.nih.gov |
| Clonal expansion: a marker of disease activity in stage 1 T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,532,731 | July 15, 2024 | June 30, 2027 | LONG, S ALICE | reporter.nih.gov |
| RNA binding proteins in end-organ autoimmune pathology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,532,453 | February 8, 2022 | January 31, 2027 | GAFFEN, SARAH L | reporter.nih.gov |
| Expanded Double Negative T cells in SLE. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,529,548 | May 1, 2010 | May 31, 2026 | TSOKOS, GEORGE C | reporter.nih.gov |
| Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-Age Families | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,528,309 | September 5, 2020 | August 31, 2025 | PATTON, SUSANA R | reporter.nih.gov |
| Role of ZBP1 in pathogenesis of Salmonella biofilms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,527,208 | May 11, 2023 | April 30, 2028 | BALACHANDRAN, SIDDHARTH | reporter.nih.gov |
| Sustained Delivery of Tizanidine for Maintenance Treatment of Moderate to Severe Spasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,527,179 | April 15, 2019 | August 31, 2025 | WATKINS, GREGORY | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| Immunologic Mechanisms and Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,525,449 | July 1, 1985 | July 31, 2030 | GRAVALLESE, ELLEN M | reporter.nih.gov |
| Neuronal and molecular mechanisms underlying neural regulation of innate immunity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,524,273 | September 12, 2017 | August 31, 2027 | SUN, JINGRU | reporter.nih.gov |
| Neuro-immune regulation of intestinal inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,522,331 | September 17, 2020 | July 31, 2025 | ARTIS, DAVID | reporter.nih.gov |
| Host's and microbiota's contribution to sexual dimorphism of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,515,770 | August 16, 2017 | November 30, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,513,409 | May 1, 2021 | February 28, 2026 | UNDERHILL, DAVID M. | reporter.nih.gov |
| Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,512,710 | July 12, 2018 | June 30, 2027 | DENSON, LEE ARMISTEAD | reporter.nih.gov |
| Finding the optimal balance of immunotherapy efficacy and toxicity. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,511,216 | June 12, 2020 | May 31, 2025 | GERBER, DAVID ERIC | reporter.nih.gov |
| Mechanisms of Gastrointestinal COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,503,469 | July 15, 2022 | June 30, 2027 | CIORBA, MATTHEW AARON | reporter.nih.gov |
| Regulation and Function of Nuclear cGAS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,498,128 | September 22, 2020 | August 31, 2025 | STETSON, DANIEL B | reporter.nih.gov |
| Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $2,495,306 | January 1, 2016 | March 31, 2024 | SHINKAZH, OLEG | reporter.nih.gov |
| Regulatory Variants in Human Skin Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,487,678 | May 1, 2020 | May 31, 2030 | KHAVARI, PAUL | reporter.nih.gov |
| KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,481,052 | September 30, 2020 | May 31, 2026 | MIGNOT, EMMANUEL J | reporter.nih.gov |
| Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,480,984 | June 1, 2007 | March 31, 2028 | NOVAK, JAN | reporter.nih.gov |
| Bidirectional Brain-Gut interactions, chronic neuroinflammation and neurodegeneration after traumatic brain injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,480,051 | August 15, 2022 | July 31, 2027 | FADEN, ALAN IRA | reporter.nih.gov |
| Imaging Neurodegeneration in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,478,045 | April 1, 2013 | June 30, 2029 | SAIDHA, SHIV | reporter.nih.gov |
| Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,477,577 | September 11, 2025 | August 31, 2028 | PRATLEY, RICHARD E | reporter.nih.gov |
| The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,474,645 | March 19, 2021 | February 28, 2026 | MARSHAK-ROTHSTEIN, ANN | reporter.nih.gov |
| New way in delivering immunomodulatory drugs in T1D | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,465,695 | February 17, 2022 | January 31, 2026 | ABDI, REZA | reporter.nih.gov |
| PET Sphingosine-1-Phosphate Receptor 1 (S1P1) radiotracer for inflammation response in multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,465,277 | September 30, 2017 | May 31, 2028 | TU, ZHUDE | reporter.nih.gov |
| High-resolution, virome-wide infection analysis in type 1 diabetes birth cohorts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,459,418 | June 1, 2024 | May 31, 2027 | ALTIN, JOHN | reporter.nih.gov |
| IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,459,074 | December 10, 2019 | November 30, 2025 | MALEK, THOMAS R | reporter.nih.gov |
| Structure, function, and modulation of claudin cation channels in the GI tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,456,433 | September 30, 2021 | July 31, 2027 | WEBER, CHRISTOPHER | reporter.nih.gov |
| Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,456,250 | September 15, 2021 | August 31, 2026 | WILSON, DAVID SCOTT | reporter.nih.gov |
| Defining how TCR strength of signal modulates Treg function | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,454,919 | September 19, 2022 | July 31, 2027 | EVAVOLD, BRIAN D | reporter.nih.gov |
| Pathogenesis of Lupus Nephritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,451,240 | May 6, 2020 | April 30, 2025 | CRAFT, JOSEPH EDGAR | reporter.nih.gov |
| SYK and ZAP70 kinases in lymphocyte selection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,450,839 | February 1, 2022 | January 31, 2027 | MÜSCHEN, MARKUS | reporter.nih.gov |
| Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,447,499 | July 27, 2022 | June 30, 2027 | NADEAU, KRISTEN JANE | reporter.nih.gov |
| How do CNS fibroblasts regulate the response to neuroinflammation? | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,446,884 | January 1, 2021 | December 31, 2025 | DANEMAN, RICHARD | reporter.nih.gov |
| Ca2+ and secretory dynamics in salivary acinar cells | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,446,451 | August 15, 2002 | June 30, 2028 | YULE, DAVID I | reporter.nih.gov |
| A Toolkit for Analysis and Visualization of Preclinical Rodent Neuroimaging Experiments | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,445,717 | April 1, 2022 | March 31, 2027 | SHATTUCK, DAVID W | reporter.nih.gov |
| Mechanisms regulating VEGF receptors in diabetic angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,443,536 | January 1, 2016 | June 30, 2025 | CHEN, HONG | reporter.nih.gov |
| Intracellular nucleic acid detection in autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,440,748 | May 15, 2010 | April 30, 2025 | STETSON, DANIEL B | reporter.nih.gov |
| Humanized Mouse Avatars for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,439,759 | September 25, 2014 | May 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,434,680 | September 4, 2023 | June 30, 2027 | FANGER, GARY | reporter.nih.gov |
| Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,434,606 | August 1, 1989 | June 30, 2025 | WEISS, MICHAEL AARON | reporter.nih.gov |
| Mechanisms by which effector T cells modulate endogenous remyelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,434,021 | July 1, 2000 | November 30, 2026 | CALABRESI, PETER A | reporter.nih.gov |
| Characterization of T cells in MOG antibody-associated disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,432,350 | July 1, 2023 | June 30, 2028 | ZAMVIL, SCOTT S | reporter.nih.gov |
| Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,430,276 | September 1, 2022 | July 31, 2027 | BEATON, ANDREA ZAWACKI | reporter.nih.gov |
| Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,428,878 | September 12, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Pooled analysis of multiple sclerosis findings on multi-site 7 Tesla MRI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,425,431 | July 1, 2021 | June 30, 2027 | HARRISON, DANIEL M | reporter.nih.gov |
| Lacritin Regulation of Homeostasis and Ocular Surface Health | NIH | National Eye Institute | 2021 to 2025 | $2,424,560 | September 1, 2021 | July 31, 2026 | LAURIE, GORDON WILLIAM | reporter.nih.gov |
| Photoresponsive materials to study matricellular signaling dynamics during crypt formation and fission | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,423,541 | August 1, 2019 | April 30, 2028 | ANSETH, KRISTI S. | reporter.nih.gov |
| Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,422,875 | February 1, 2021 | January 31, 2026 | MARTH, JAMEY | reporter.nih.gov |
| Role of dietary fiber-microbiota Interactions in the development and function of small intestinal T cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,421,990 | September 1, 2021 | July 31, 2026 | CERVANTES BARRAGAN, LUISA | reporter.nih.gov |
| Immunomodulatory Therapy for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,420,195 | September 1, 2018 | August 31, 2025 | CHEN, RIDONG | reporter.nih.gov |
| Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,419,724 | March 18, 2022 | December 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| Glycosyltransferase Function in Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,418,000 | September 15, 1994 | March 31, 2027 | MARTH, JAMEY | reporter.nih.gov |
| Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,415,579 | April 1, 2020 | March 31, 2026 | DEBOER, MARK DANIEL | reporter.nih.gov |
| Virome and Immune Responses associated with IA and Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,412,388 | March 5, 2024 | January 31, 2027 | LLOYD, RICHARD E | reporter.nih.gov |
| Genetic Linkage in Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,409,142 | July 1, 1987 | May 31, 2027 | KOTTYAN, LEAH CLAIRE | reporter.nih.gov |
| Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,405,842 | February 15, 2016 | January 31, 2026 | LAU, KEN S | reporter.nih.gov |
| Continuation of The Collaborative Islet Transplantation Registry (CITR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,074 | September 15, 2022 | June 30, 2027 | PAYNE, ELIZABETH HOLLY | reporter.nih.gov |
| Leveraging early-life microbes to prevent type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,398,489 | April 1, 2023 | February 29, 2028 | SILVERMAN, MICHAEL A | reporter.nih.gov |
| Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,397,988 | March 1, 2022 | February 28, 2027 | DOUGAN, MICHAEL LAWRENCE | reporter.nih.gov |
| Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity. | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,397,078 | June 1, 2017 | October 31, 2027 | PESTKA, JAMES J | reporter.nih.gov |
| Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,395,247 | May 23, 2022 | March 31, 2027 | DE BOER, IAN H | reporter.nih.gov |
| Neural control of pancreatic endocrine function in obesity and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,392,222 | January 6, 2021 | December 31, 2025 | STANLEY, SARAH AMY | reporter.nih.gov |
| Scalable and transplantable pancreatic islet organoids with engineered oxygenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,390,830 | September 1, 2025 | August 31, 2029 | KOMATSU, HIROTAKE | reporter.nih.gov |
| A mechanism to minimize auto-reactivity in the tissue-resident memory T cell pool | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,390,315 | June 1, 2021 | May 31, 2026 | MEMPEL, THORSTEN ROMAN | reporter.nih.gov |
| Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,389,178 | September 1, 2021 | February 28, 2024 | O'NEILL, JOHN DAVID | reporter.nih.gov |
| Molecular Characterization of Progressive Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,384,181 | September 1, 2023 | July 31, 2027 | MAIER, LISA A | reporter.nih.gov |
| Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,379,500 | September 8, 2022 | August 31, 2027 | SCHOENEBERG, JOHANNES | reporter.nih.gov |
| Unraveling strain-level variation in the induction of anti-inflammatory responses in the intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,378,553 | January 1, 2021 | December 31, 2026 | AHERN, PHILIP PATRICK | reporter.nih.gov |
| Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,372,392 | February 1, 2022 | January 31, 2027 | COLONNA, MARCO | reporter.nih.gov |
| Strengths-Based Multi-Level Behavioral Intervention to Promote Resilience and Self-Management in Youth with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,369,928 | July 20, 2022 | May 31, 2028 | HILLIARD, MARISA ELLEN | reporter.nih.gov |
| Post-Initiation control of transcription in inflammatory macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,363,024 | December 23, 2019 | November 30, 2025 | ROGATSKY, INEZ | reporter.nih.gov |
| Control of Neutrophilic Inflammation in Intestinal Health and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,362,552 | September 1, 2016 | July 31, 2025 | MCCORMICK, BETH A | reporter.nih.gov |
| Regulation of pancreatic islet cell fate | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,361,366 | August 1, 2009 | July 31, 2027 | SUSSEL, LORI | reporter.nih.gov |
| Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies | NIH | National Institute on Aging | 2025 | $2,361,361 | September 1, 2025 | August 31, 2030 | CEDARBAUM, JESSE | reporter.nih.gov |
| Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children with Newly Diagnosed Diabetes.” | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,359,048 | May 1, 2023 | April 30, 2029 | LENNERZ, BELINDA S | reporter.nih.gov |
| Statistical Methods for Multilevel Multivariate Functional Studies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,357,762 | January 1, 2009 | June 30, 2027 | CRAINICEANU, CIPRIAN M | reporter.nih.gov |
| Metabolic Landscape of the Aging Lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,355,987 | May 15, 2020 | April 30, 2026 | BARNES, JARROD W. | reporter.nih.gov |
| Mount Sinai NYC Genetics Research Center: Multi-omic integration across data-types, cell niches and populations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,355,463 | September 30, 2002 | June 30, 2027 | CHO, JUDY H. | reporter.nih.gov |
| Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,355,154 | September 21, 2021 | July 31, 2026 | BOGYO, MATTHEW | reporter.nih.gov |
| Neuronal antigen surveillance and autoimmunity in CNS demyelinating disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,354,214 | July 15, 2020 | April 30, 2025 | HOWE, CHARLES LEE | reporter.nih.gov |
| Lymphatic ERG signaling in scleroderma fibrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,352,935 | July 7, 2022 | May 31, 2027 | TROJANOWSKA, MARIA | reporter.nih.gov |
| Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,352,906 | September 1, 2025 | August 31, 2028 | BERGENSTAL, RICHARD MAURITZ | reporter.nih.gov |
| Intermittent fasting restores salivary gland function in Sjögren’s syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,348,947 | March 3, 2021 | February 28, 2027 | ZHOU, JING | reporter.nih.gov |
| Protein-polymer nanomedicine for Sjogren's Syndrome | NIH | National Eye Institute | 2021 to 2025 | $2,348,434 | March 1, 2017 | May 31, 2025 | HAMM-ALVAREZ, SARAH F | reporter.nih.gov |
| Muscle building supplement HMB for remyelination | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,347,150 | July 1, 2020 | June 30, 2025 | PAHAN, KALIPADA | reporter.nih.gov |
| Thinking Outside the Clinic: A Digital Health Approach for Young Adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,345,203 | April 1, 2020 | March 31, 2026 | CATHERINE STANGER, CATHERINE STANGER CATHERINE STANGER | reporter.nih.gov |
| Care partner-assisted ImplementatiOn of Patch HybrId Closed Loop Insulin Delivery for Older Adults with T1D (COPILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,345,176 | September 3, 2025 | August 31, 2028 | HENDERSON, ROBERT J | reporter.nih.gov |
| Origin and Function of Double Negative T cells in Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,344,269 | November 19, 2020 | October 31, 2025 | RANDALL, TROY D | reporter.nih.gov |
| Islet-specific CD8 T cells in the pathogenesis of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,344,031 | August 20, 2013 | May 31, 2030 | NAKAYAMA, MAKI | reporter.nih.gov |
| Autoimmune Regulator gene (Aire)-mediated tolerance to pregnancy-associated self-antigens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,342,665 | August 21, 2019 | July 31, 2025 | MACKENZIE, TIPPI | reporter.nih.gov |
| Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,332,346 | September 15, 2020 | December 31, 2022 | TSE, HUBERT M | reporter.nih.gov |
| Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,328,420 | September 20, 2019 | May 31, 2024 | SYKES, MEGAN | reporter.nih.gov |
| Sleep optimization to improve glycemic control in adults with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,328,270 | July 1, 2020 | April 30, 2026 | MARTYN-NEMETH, PAMELA ANN | reporter.nih.gov |
| Impact of symbiotic protists on intestinal T cell homeostasis and inflammation. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,328,152 | March 1, 2021 | February 28, 2026 | HOWITT, MICHAEL R | reporter.nih.gov |
| Sex and gender differences in lupus - intersection between immunometabolism, epigenetic remodeling and cardiac involvement | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,327,472 | August 16, 2021 | July 31, 2025 | JEFFERIES, CAROLINE | reporter.nih.gov |
| The KQ1 serum study: soluble biomarkers for T1D risk, development & progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,326,300 | February 1, 2024 | January 31, 2026 | HOMANN, DIRK | reporter.nih.gov |
| Identifying lifelong factors that impact brain health and outcomes in type 1 diabetes: The Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,325,031 | September 1, 2021 | July 31, 2026 | FELDMAN, EVA LUCILLE | reporter.nih.gov |
| Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,322,594 | June 1, 2018 | September 30, 2025 | REIZIS, BORIS | reporter.nih.gov |
| Transcriptional and Translational Mechanisms Governing Beta Cell Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,322,333 | March 1, 2002 | April 30, 2027 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Type I Interferon induction of neuroinflammation mediates neuropsychiatric lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,321,217 | August 18, 2025 | July 31, 2028 | CARROLL, MICHAEL CRAIG | reporter.nih.gov |
| Immune Functions of Cutaneous Nociceptors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,315,978 | March 1, 2017 | May 31, 2027 | KAPLAN, DANIEL H | reporter.nih.gov |
| Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,314,029 | February 2, 2023 | January 31, 2028 | KESELOWSKY, BENJAMIN GEORGE | reporter.nih.gov |
| Derivation of pancreatic islet-like organoids from human gastric stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,313,256 | August 24, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Glial Mechanisms Governing the Removal and Repair of Degenerating Myelin | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,312,213 | September 1, 2021 | August 31, 2026 | HILL, ROBERT A. | reporter.nih.gov |
| Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,309,947 | August 19, 2022 | July 31, 2027 | BOUTJDIR, MOHAMED | reporter.nih.gov |
| Identification of key regulators in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,309,449 | August 1, 2014 | April 30, 2026 | WANG, WEI | reporter.nih.gov |
| Regulation of Peripheral Neuropathic Pain by B Cells | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,308,227 | March 15, 2022 | February 28, 2027 | GRACE, PETER M | reporter.nih.gov |
| Gene discoveries in subjects with Crohn's disease of African descent | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,305,204 | March 1, 2011 | June 30, 2025 | KUGATHASAN, SUBRA | reporter.nih.gov |
| MASPs as therapeutic targets in complement-mediated diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,302,777 | March 18, 2020 | February 28, 2025 | SONG, WENCHAO | reporter.nih.gov |
| Type III interferon Control of Mucosal Immunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,301,166 | August 1, 2017 | December 31, 2026 | ZANONI, IVAN | reporter.nih.gov |
| T cell Epitope Discovery in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,300,582 | July 5, 2017 | June 30, 2026 | PALMER, BRENT E | reporter.nih.gov |
| Evolution of autoreactive GC and epitope spreading in lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,299,924 | July 13, 2018 | June 30, 2028 | CARROLL, MICHAEL CRAIG | reporter.nih.gov |
| Engineering optimization and scaling enables high quality pancreatic islet cryopreservation for banking and transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,294,596 | September 22, 2021 | July 31, 2025 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Mechanisms of autoimmunity in myasthenia gravis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,293,368 | November 4, 2015 | August 31, 2026 | O'CONNOR, KEVIN C | reporter.nih.gov |
| Innate mechanisms of regulation of Th17 responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,291,191 | December 1, 2016 | December 31, 2026 | PASARE, CHANDRASHEKHAR | reporter.nih.gov |
| Thymic selection abnormalities in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,291,187 | June 26, 2023 | May 31, 2028 | SYKES, MEGAN | reporter.nih.gov |
| Immune Interactions with the Mucus-Associated Microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,287,659 | July 12, 2021 | June 30, 2027 | MAYNARD, CRAIG L | reporter.nih.gov |
| Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,286,893 | June 1, 2020 | May 31, 2026 | GNJATIC, SACHA | reporter.nih.gov |
| Aberrant DNA Repair and Lupus | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,286,049 | July 6, 2020 | March 31, 2024 | SWEASY, JOANN B. | reporter.nih.gov |
| University of Miami IBD Genetic Research Center: Understanding the Genetic Architecture of IBD in the South Florida community | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,285,492 | September 30, 2022 | June 30, 2027 | MCCAULEY, JACOB L | reporter.nih.gov |
| Mechanisms controlling ABC differentiation and function in SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,285,313 | July 1, 2022 | May 31, 2027 | PERNIS, ALESSANDRA B | reporter.nih.gov |
| Biochemical Mechanism of Beta-Cell Destruction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,284,193 | June 1, 2022 | March 31, 2027 | CORBETT, JOHN A | reporter.nih.gov |
| Morning Meal-Associated Priming of the Liver | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,282,667 | September 24, 2021 | July 31, 2025 | CHERRINGTON, ALAN D | reporter.nih.gov |
| Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,282,116 | September 1, 2022 | August 31, 2025 | JOHNSTONE, ANDREA LYNN | reporter.nih.gov |
| Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,281,489 | September 19, 2022 | July 31, 2028 | HOLLENBACH, JILL ALLISON | reporter.nih.gov |
| Diabetes in African Youth: Improving Glucose Time-In-Range | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,281,071 | April 1, 2022 | March 31, 2027 | MORAN, ANTOINETTE M. | reporter.nih.gov |
| High-Intensity, dynamic-stability gait training in people with multiple sclerosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,280,989 | September 15, 2022 | June 30, 2027 | SCHMIT, BRIAN D | reporter.nih.gov |
| Activity Probes to Guide Precision Microbiome Therapy | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,279,811 | September 1, 2024 | May 31, 2029 | LONGMAN, RANDY S | reporter.nih.gov |
| A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,277,236 | July 5, 2022 | July 31, 2025 | FANGER, GARY | reporter.nih.gov |
| Genomics of Inflammatory Bowel Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,275,152 | September 20, 2019 | August 31, 2025 | KOTTYAN, LEAH CLAIRE | reporter.nih.gov |
| Integrative and longitudinal multi-omic risk assessment in inflammatory bowel disease progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,272,364 | September 30, 2022 | June 30, 2027 | KUGATHASAN, SUBRA | reporter.nih.gov |
| Rip Proteins in Innate Immune Signaling | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,272,136 | December 15, 2008 | August 31, 2025 | KELLIHER, MICHELLE ALICE | reporter.nih.gov |
| Immunogenomics and Systems Biology Core | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,270,385 | March 18, 2022 | December 31, 2026 | GUDJONSSON, JOHANN ELI | reporter.nih.gov |
| Investigating How TLR7 Activates and TLR9 Regulates Systemic Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,270,215 | May 1, 2021 | April 30, 2026 | SHLOMCHIK, MARK J | reporter.nih.gov |
| Reducing innate inflammation in new onset T1D with Lactobacillus plantarum | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,267,995 | August 21, 2020 | May 31, 2026 | HESSNER, MARTIN J | reporter.nih.gov |
| Purinergic modulation of the autoimmune vascular phenotype | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,262,808 | January 1, 2018 | December 31, 2027 | KNIGHT, JASON | reporter.nih.gov |
| Exacerbation of Colitis by Enterobacteriaceae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,260,715 | January 15, 2015 | March 31, 2026 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,260,661 | September 15, 2020 | June 30, 2025 | CHEN, SHUIBING | reporter.nih.gov |
| Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,260,647 | February 15, 2022 | November 30, 2025 | WILSON, MICHAEL R | reporter.nih.gov |
| Advanced Statistical Analytics of MRI in MS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,257,955 | April 1, 2020 | January 31, 2026 | SHINOHARA, RUSSELL TAKESHI | reporter.nih.gov |
| Utilizing continuous ketone monitors to enable safe use of SGLT inhibitors in patients with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,257,919 | September 11, 2025 | August 31, 2028 | PETTUS, JEREMY H | reporter.nih.gov |
| Glycolytic metabolites, Calcium entry and Sjogren’s syndrome | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,257,810 | September 19, 2022 | June 30, 2027 | SINGH, BRIJ B | reporter.nih.gov |
| Defining mechanisms of CD8 T cell exhaustion in T1D | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,256,570 | April 10, 2020 | March 31, 2026 | LONG, S ALICE | reporter.nih.gov |
| A stem cell activated cryogel bioscaffold that restores islet bioenergetics while providing oxygen and nutrients at extravascular sites of transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,251,861 | April 1, 2022 | March 31, 2027 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Interrogating the intersection between diet and ocular autoimmunity | NIH | National Eye Institute | 2022 to 2025 | $2,251,397 | April 1, 2022 | March 31, 2027 | PLAFKER, SCOTT M | reporter.nih.gov |
| Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $2,249,923 | February 1, 2017 | January 31, 2025 | OLSEN, NANCY J | reporter.nih.gov |
| University of Minnesota Clinical Center for the Restoration of Impaired Awareness of Hypoglycemia in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,249,591 | September 25, 2022 | December 31, 2027 | SEAQUIST, ELIZABETH R. | reporter.nih.gov |
| Engineering Tregs for autoimmune diabetes therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,249,376 | September 5, 2025 | August 31, 2028 | FIFE, BRIAN T | reporter.nih.gov |
| Virtual Histology for Assessing MS Pathologies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,247,732 | December 1, 2020 | November 30, 2025 | SONG, SHENG-KWEI | reporter.nih.gov |
| Bacterial adaptions in host-microbe interactions. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,240,628 | March 11, 2022 | February 28, 2027 | CHU, HIUTUNG | reporter.nih.gov |
| Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,239,160 | May 10, 2022 | April 1, 2025 | RAMSEY-GOLDMAN, ROSALIND | reporter.nih.gov |
| Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,237,890 | March 1, 2021 | February 28, 2026 | GOODMAN, WENDY ANN | reporter.nih.gov |
| Mechanisms that alter lymphatic transport in inflammatory bowel disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,237,567 | February 7, 2022 | January 31, 2027 | RANDOLPH, GWENDALYN J | reporter.nih.gov |
| Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort | NIH | National Eye Institute | 2025 | $2,236,075 | May 1, 2004 | August 31, 2029 | KEMPEN, JOHN H | reporter.nih.gov |
| Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,235,780 | February 3, 2020 | January 31, 2030 | KUCHROO, VIJAY K. | reporter.nih.gov |
| Role of Sam68 in Proinflammatory Signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,234,964 | April 1, 2022 | February 28, 2027 | RAMAKRISHNAN, PARAMESWARAN | reporter.nih.gov |
| Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of Crohnâs Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,232,504 | September 1, 2020 | June 30, 2026 | SNAPPER, SCOTT B | reporter.nih.gov |
| Mechanisms driving extrafollicular polyreactive B cell lineages in partial RAG deficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,232,177 | September 22, 2021 | August 31, 2027 | WALTER, JOLAN ESZTER | reporter.nih.gov |
| Targeting the Integrated Stress Response to Protect Oligodendrocyte lineage Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,231,775 | December 1, 1996 | December 31, 2024 | POPKO, BRIAN J | reporter.nih.gov |
| Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic Mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,229,920 | April 15, 2017 | March 31, 2028 | WEIRAUCH, MATTHEW TYSON | reporter.nih.gov |
| Contributions of autophagy-related genes in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,228,235 | August 18, 2023 | July 31, 2027 | NATH, SWAPAN K. | reporter.nih.gov |
| Targeting Tfh Cell Metabolic Regulation in SLE and SLE-Associated Atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,227,644 | May 20, 2020 | April 30, 2026 | RATHMELL, JEFFREY C. | reporter.nih.gov |
| Metabolic regulators of Treg/Th17 balance in CNS autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,226,462 | September 21, 2022 | July 31, 2027 | KUCHROO, VIJAY K. | reporter.nih.gov |
| Enabling Fully Automated Closed Loop Control in Type 1 Diabetes Through an Artificial Intelligence Meal Detection Algorithm and Pramlintide | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,222,737 | August 20, 2021 | June 30, 2026 | JACOBS, PETER G | reporter.nih.gov |
| TSPO-PET and MRI Imaging as Novel Imaging Tools for Autoimmune Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,221,278 | May 15, 2022 | April 30, 2027 | STERIADE, CLAUDE | reporter.nih.gov |
| CD4 AND CD8 T CELL EPITOPES RECOGNIZED IN AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,220,000 | September 30, 2025 | September 29, 2026 | STERN, LAWRENCE | reporter.nih.gov |
| Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,219,663 | September 19, 2022 | July 31, 2025 | GARCIA, JOE G. N. | reporter.nih.gov |
| Diabetic Foot Consortium Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,218,022 | September 21, 2018 | December 31, 2027 | SEN, CHANDAN K | reporter.nih.gov |
| Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,215,775 | February 1, 2022 | January 31, 2027 | JEWELL, CHRISTOPHER M | reporter.nih.gov |
| Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial | NIH | National Institute of Nursing Research | 2022 to 2025 | $2,209,310 | September 26, 2022 | June 30, 2027 | MCGINLEY, MARISA | reporter.nih.gov |
| Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,209,225 | January 25, 2023 | November 30, 2027 | MAMULA, MARK J | reporter.nih.gov |
| Systemic immunoregulatory consequences of bacterial translocation during health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,209,196 | September 21, 2021 | June 30, 2026 | MEISEL, MARLIES | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 42 | $252.4 million | 0 | $0 |
| University of South Florida | Tampa, FL | 13 | $199.4 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 117 | $139.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 107 | $127.5 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 120 | $123.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 74 | $113.2 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 91 | $101.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 80 | $100.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 91 | $88.7 million | 0 | $0 |
| Yale University | New Haven, CT | 83 | $87.2 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 52 | $81.4 million | 0 | $0 |
| Emory University | Atlanta, GA | 36 | $80.6 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 77 | $77 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 36 | $75.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 67 | $73.4 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 47 | $69.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 62 | $68.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 74 | $67.2 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 46 | $63.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 59 | $61.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 58 | $60.5 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 2 | $60.5 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 30 | $60.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 55 | $60 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 42 | $58.1 million | 0 | $0 |
| University of Chicago | Chicago, IL | 33 | $57.6 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 46 | $57.2 million | 0 | $0 |
| University of Florida | Gainesville, FL | 61 | $56.7 million | 0 | $0 |
| University of Washington | Seattle, WA | 49 | $56.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 37 | $51.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 42 | $48.5 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 41 | $48.3 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 43 | $48 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 38 | $47.5 million | 0 | $0 |
| Jaeb Center for Health Research, Inc. | Tampa, FL | 3 | $47 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 59 | $45.8 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 38 | $45.5 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 32 | $42.7 million | 0 | $0 |
| Duke University | Durham, NC | 42 | $39.7 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 37 | $38.1 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 17 | $37.7 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 15 | $36.6 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 30 | $33.7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 32 | $32.4 million | 0 | $0 |
| Hospital for Special Surgery | New York, NY | 26 | $30.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 29 | $28.5 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 21 | $27.3 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 15 | $27.2 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 31 | $26.5 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 37 | $25.7 million | 0 | $0 |
| Feinstein Institute for Medical Research | Manhasset, NY | 13 | $25.7 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 11 | $24.9 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 17 | $24.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 27 | $24.2 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 14 | $23.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 20 | $22.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 13 | $22.7 million | 0 | $0 |
| Ohio State University | Columbus, OH | 26 | $21.4 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 9 | $20.9 million | 0 | $0 |
| University of Louisville | Louisville, KY | 9 | $20.1 million | 0 | $0 |
| Rise Therapeutics, LLC | Rockville, MD | 10 | $19.9 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 15 | $19.2 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 28 | $18.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 25 | $18.6 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 17 | $18.4 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 18 | $17.1 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 14 | $16 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 15 | $15.8 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 13 | $15.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 24 | $15.1 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 21 | $14.5 million | 0 | $0 |
| Sage Bionetworks | Seattle, WA | 1 | $14.5 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 13 | $14.4 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 18 | $14 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 13 | $13.9 million | 0 | $0 |
| George Washington University | Washington, DC | 8 | $13.6 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 21 | $13.3 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 12 | $12.4 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 14 | $12.1 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 8 | $11.3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 14 | $11.1 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 12 | $11.1 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 9 | $10.7 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 14 | $10.6 million | 0 | $0 |
| National Jewish Health | Denver, CO | 13 | $10.5 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 8 | $10.1 million | 0 | $0 |
| Wayne State University | Detroit, MI | 11 | $10 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 5 | $10 million | 0 | $0 |
| University of Houston | Houston, TX | 8 | $9.8 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 8 | $9.8 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 8 | $9.6 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 7 | $9.4 million | 0 | $0 |
| Connecticut Children's Medical Center | Hartford, CT | 3 | $9.4 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 6 | $9.3 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 7 | $9.2 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 3 | $8.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 11 | $8.4 million | 0 | $0 |
| Upstate Medical University | Syracuse, NY | 4 | $8.3 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 7 | $7.8 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 15 | $7.8 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,717 | $1,036,792,908 | 0 | $0 |
| 2024 | 1,732 | $924,477,330 | 0 | $0 |
| 2023 | 1,777 | $942,082,729 | 0 | $0 |
| 2022 | 1,861 | $922,390,670 | 0 | $0 |
| 2021 | 1,828 | $925,403,661 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.